UMNファーマ
IPOUMNファーマ was founded in 2004, is headquartered in Akita, Japan, and lists 11–50 employees.
- Headquarters
- Akita
- Employees
- 11–50
- Founded
- 2004
- Business Model
- B2B
- Website
- umnpharma.com
About
UMN Pharma is a Japanese biopharmaceutical venture company founded in 2004 and headquartered in Akita, Japan, specializing in next-generation vaccine development using proprietary protein expression technology. The company developed recombinant influenza vaccines and collaborated with Shionogi, Daiichi Sankyo, and Protein Sciences on norovirus and Zika vaccine programs. In 2017, Shionogi acquired UMN Pharma and by 2019 it became a wholly-owned subsidiary. As of October 2024, Shionogi announced the reorganization and liquidation of UMN Pharma, with its Akita production facility transferring to Shionogi Pharma.
Summary
UMNファーマ is a Biotech company based in Akita, Japan, founded in 2004. It lists 11–50 employees.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/umn"><img src="https://indexed.vc/api/badge/company/umn" alt="UMNファーマ on Indexed.vc" width="260" height="76" /></a>